idecabtagene vicleucel,lenalidomide,isatuximab,carfilzomib,dexamethasone
bms,2seventy bio,Sanofi,amgen
['ikema', 'mmsm', 'karmma 2', 'karmma']
#ash22 post hoc ikema analysis by my former boss . mpfs 24.7 mo with isa-kd in pts with functional high-risk #mmsm (pd 12 mo). better than karmma 2a (dor 16mo). tom's excellent thought: continuous tx vs one-and-done car-t might play a role, but more study needed. 
Asst Professor @UWMedicine @fredhutch, s/p @PennIMResidents ??@UCSFCancer training. Myeloma #MMsm #cellphonesandcelltherapies ????

COI: https://t.co/3Uuojuio6R